Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00161733 | Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery | PHASE3 | COMPLETED | - | — | — | Sep 1, 2002 | Nov 1, 2004 | Apr 5, 2017 | 22 | United States |
| Name | Type | Description |
|---|---|---|
| Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) | DRUG | - |
| TISSEEL VH fibrin sealant | DRUG | - |
Inclusion Criteria: All subjects accepted for this study must be: * Informed of the nature of the study and have provided written informed consent * \>= 18 years of age * Scheduled to undergo cardiac surgery requiring CPB and median sternotomy * Able and willing to comply with the procedures requi...